Shares of Exantas Capital Corp (NYSE:XAN) have earned an average broker rating score of 1.75 (Buy) from the four analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating on the company. Exantas Capital’s rating score has improved by 12.5% in the last three months as a result of various analysts’ upgrades and downgrades.

Brokerages have set a 1-year consensus price target of $12.33 for the company and are expecting that the company will post $0.21 EPS for the current quarter, according to Zacks. Zacks has also given Exantas Capital an industry rank of 104 out of 255 based on the ratings given to its competitors.

XAN has been the topic of a number of recent analyst reports. Raymond James initiated coverage on shares of Exantas Capital in a research note on Monday, July 30th. They set an “outperform” rating and a $12.00 price target on the stock. BTIG Research initiated coverage on shares of Exantas Capital in a research note on Monday, October 8th. They set a “buy” rating and a $13.00 price target on the stock. JMP Securities upped their price target on shares of Exantas Capital from $12.00 to $12.50 and gave the company a “market outperform” rating in a research note on Thursday, August 9th. Finally, ValuEngine upgraded shares of Exantas Capital from a “hold” rating to a “buy” rating in a research note on Friday, July 6th.

Exantas Capital stock traded down $0.13 during mid-day trading on Friday, reaching $10.91. 188,900 shares of the company traded hands, compared to its average volume of 195,092. The company has a current ratio of 166.87, a quick ratio of 166.86 and a debt-to-equity ratio of 2.37. Exantas Capital has a fifty-two week low of $8.51 and a fifty-two week high of $12.09. The firm has a market capitalization of $354.25 million, a price-to-earnings ratio of -12.83 and a beta of 0.90.

Exantas Capital (NYSE:XAN) last issued its quarterly earnings results on Wednesday, August 1st. The company reported $0.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.07. Exantas Capital had a net margin of 54.24% and a negative return on equity of 2.89%. The business had revenue of $13.65 million for the quarter, compared to analyst estimates of $10.40 million. On average, sell-side analysts predict that Exantas Capital will post 0.61 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be issued a $0.15 dividend. This is an increase from Exantas Capital’s previous quarterly dividend of $0.10. This represents a $0.60 annualized dividend and a dividend yield of 5.50%. The ex-dividend date is Thursday, September 27th. Exantas Capital’s dividend payout ratio is -69.77%.

Several hedge funds have recently added to or reduced their stakes in XAN. Bank of America Corp DE purchased a new stake in shares of Exantas Capital in the 2nd quarter valued at $106,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Exantas Capital in the 2nd quarter valued at $110,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Exantas Capital in the 2nd quarter valued at $113,000. First Quadrant L P CA purchased a new stake in shares of Exantas Capital in the 2nd quarter valued at $130,000. Finally, Creative Planning purchased a new stake in shares of Exantas Capital in the 2nd quarter valued at $138,000. 51.96% of the stock is currently owned by institutional investors and hedge funds.

About Exantas Capital

Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, such as first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, and commercial mortgage-backed securities.

Featured Article: How do investors use RSI to grade stocks?

Get a free copy of the Zacks research report on Exantas Capital (XAN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.